Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Outcome of Patients With Lower Urinary Symptoms Suggestive of Benign Prostatic Hyperplasia and Treated With Alfuzosin 10 mg Once Daily for 3 Months in China

NCT00280605 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00280605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00280605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Outcome of Patients With Lower Urinary Symptoms Suggestive of Benign Prostatic Hyperplasia and Treated With Alfuzosin 10 mg Once Daily for 3 Months in China
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2005
Completion date
February 28, 2006
Enrollment
200
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic hyperplasia